Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model.

Abstract:

:Many vaccines are dependent on adjuvants to augment the immunizing process. The vaccines being developed for active specific immunotherapy of cancer have also usually included an adjuvant in the clinical studies. Several cytokines have been identified which are participants in the immune response to new antigenic stimulation. We investigated the potential of interleukin 1 (IL-1) to serve as an adjuvant when administered either locally with the vaccine or given systemically. Using a weakly immunogenic syngeneic murine lung cancer tumor system (Line 1, BALB/cByJ mice), we have administered recombinant human IL-1 alpha, recombinant human IL-1 beta, and the peptide fragment 163-171 of IL-1 beta in combination with a vaccine of radiated tumor cells. We demonstrated an improved vaccine effectiveness with all three types of IL-1 molecules. The effect was both dose dependent and duration dependent (the number of daily doses given). When IL-1 was administered at a site remote from the vaccine, it functioned as well as when administered at the vaccine site indicating that IL-1 functions as a systemic adjuvant. A requirement for administering the IL-1 during the 10-day period following the vaccine, rather than later, was observed. A detrimental effect on weight gain was seen with high doses of IL-1 alpha, IL-1 beta, and the peptide but some lower doses were effective in the adjuvant function without impairing weight gain. When eight daily doses of IL-1 were given following the vaccine, 70-100% of the mice became tumor free, while mice receiving vaccine alone were only 0-20% tumor free. We conclude that IL-1 appears promising as an adjuvant to vaccines and is highly effective in this model of active specific immunotherapy for cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

McCune CS,Marquis DM

subject

Has Abstract

pub_date

1990-02-15 00:00:00

pages

1212-5

issue

4

eissn

0008-5472

issn

1538-7445

journal_volume

50

pub_type

杂志文章
  • Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.

    abstract::We describe a method to postlabel, in vivo, biotinylated monoclonal antibodies pretargeted onto tumor deposits when most of the non-tumor-bound antibodies have already been cleared as avidin-bound complexes. The application of this principle to tumor detection by immunoscintigraphy was tested in 20 patients with histo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Paganelli G,Magnani P,Zito F,Villa E,Sudati F,Lopalco L,Rossetti C,Malcovati M,Chiolerio F,Seccamani E

    更新日期:1991-11-01 00:00:00

  • Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

    abstract::Medulloblastoma and central nervous system primitive neuroectodermal tumors (CNS-PNET) are aggressive, poorly differentiated brain tumors with limited effective therapies. Using Sleeping Beauty (SB) transposon mutagenesis, we identified novel genetic drivers of medulloblastoma and CNS-PNET. Cross-species gene expressi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1261

    authors: Beckmann PJ,Larson JD,Larsson AT,Ostergaard JP,Wagner S,Rahrmann EP,Shamsan GA,Otto GM,Williams RL,Wang J,Lee C,Tschida BR,Das P,Dubuc AM,Moriarity BS,Picard D,Wu X,Rodriguez FJ,Rosemarie Q,Krebs RD,Molan AM,Dem

    更新日期:2019-03-01 00:00:00

  • Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

    abstract::Little is known about the genetic changes underlying invasive tumor growth in bladder cancer. Because alterations that are linked to invasive tumor growth may be detectable in minimally invasive (stage pT1) but not in noninvasive (stage pTa) tumors, we searched for genetic differences between 28 pTa and 28 papillary p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Richter J,Jiang F,Görög JP,Sartorius G,Egenter C,Gasser TC,Moch H,Mihatsch MJ,Sauter G

    更新日期:1997-07-15 00:00:00

  • Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.

    abstract::CX3CR1+ macrophages in the intestinal lamina propria contribute to gut homeostasis through the immunomodulatory interleukin IL10, but there is little knowledge on how these cells or the CX3CR1 receptor may affect colorectal carcinogenesis. In this study, we show that CX3CR1-deficient mice fail to resolve gut inflammat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2501

    authors: Marelli G,Erreni M,Anselmo A,Taverniti V,Guglielmetti S,Mantovani A,Allavena P

    更新日期:2017-08-15 00:00:00

  • MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.

    abstract::Chemotherapy, radiation, and growth inhibitory drugs preferentially eliminate actively growing cancer cells. Cancer recurrence is currently thought to be due to nondividing cancer stem/progenitor cells that are resistant to these therapies. Different therapeutic approaches need to be considered for the elimination of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2249

    authors: Engelmann K,Shen H,Finn OJ

    更新日期:2008-04-01 00:00:00

  • Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.

    abstract::Thrombospondin-1 (TSP-1) is a potent inhibitor of tumor growth and angiogenesis. The antiangiogenic activity of TSP-1 has been mapped to the procollagen homology region and the type 1 repeats (TSR) using synthetic peptides. To elucidate the molecular mechanisms that are involved in the inhibition of tumor growth by th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Miao WM,Seng WL,Duquette M,Lawler P,Laus C,Lawler J

    更新日期:2001-11-01 00:00:00

  • Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico.

    abstract::Some, but not all, epidemiological studies have suggested that dichlorodiphenyltrichloroethane (DDT) may play a role in the development of breast cancer. These investigations have been conducted in countries where this substance has been banned for at least 20 years. We conducted a study in Mexico, a country in which ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: López-Carrillo L,Blair A,López-Cervantes M,Cebrián M,Rueda C,Reyes R,Mohar A,Bravo J

    更新日期:1997-09-01 00:00:00

  • Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.

    abstract::Sixteen patients with previously treated acute nonlymphocytic leukemia or chronic myelogenous leukemia in blast crisis were given one to three courses of esorubicin by continuous infusion over 48 h. Dosage levels extended from 35 to 85 mg/m2. Four patients showed partial responses of short duration. Nonhematological t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kreis W,Rottach C,Budman DR,Chan K,Schulman P,Allen SL,Weiselberg L,Vinciguerra V

    更新日期:1988-10-01 00:00:00

  • Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas.

    abstract::Chronic exposure to UV radiation (UVR), especially in the UVA (315-400 nm) and UVB (280-315 nm) spectrum of sunlight, is the major risk factor for the development of nonmelanoma skin cancer. UVR is a complete carcinogen, which both initiates and promotes carcinogenesis. We found that protein kinase C epsilon (PKCepsil...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1881

    authors: Wheeler DL,Martin KE,Ness KJ,Li Y,Dreckschmidt NE,Wartman M,Ananthaswamy HN,Mitchell DL,Verma AK

    更新日期:2004-11-01 00:00:00

  • Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter.

    abstract::The percentages of dark keratinocytes was quantitatively assessed in normal epidermis of Sencar mice before and after birth and in adult epidermis after topical application of several compounds of varying promoting efficiency. The percentage of dark keratinocytes reached a maximum at the 19th day of gestation (approxi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Klein-Szanto AJ,Slaga TJ

    更新日期:1981-11-01 00:00:00

  • Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.

    abstract::A rational monoclonal antibody (mAb)-based antitumor therapy approach has previously been shown to eradicate various established experimental and carcinogen-induced tumors in a majority of mice. This therapy comprised an agonistic mAb reactive with tumor necrosis factor-related apoptosis-inducing ligand receptor (DR5)...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0941

    authors: Teng MW,Westwood JA,Darcy PK,Sharkey J,Tsuji M,Franck RW,Porcelli SA,Besra GS,Takeda K,Yagita H,Kershaw MH,Smyth MJ

    更新日期:2007-08-01 00:00:00

  • The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine.

    abstract::The inhibition of ribosomal RNA (rRNA) maturation by 5-fluorouridine (FUrd) in Novikoff hepatoma cells appears to depend upon the incorporation of the analog into the 45 S rRNA precursor. Precursor synthesized in the presence of FUrd is not processed into mature rRNA, but precursor synthesized in the absence of the an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wilkinson DS,Tlsty TD,Hanas RJ

    更新日期:1975-11-01 00:00:00

  • Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma.

    abstract::It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Song P,Sekhon HS,Jia Y,Keller JA,Blusztajn JK,Mark GP,Spindel ER

    更新日期:2003-01-01 00:00:00

  • A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.

    abstract::Retinoic acid (RA) is a master epigenetic regulator that plays a pivotal role in both breast morphogenesis and development. Here, we show for the first time that RA, via the RA receptor alpha (RARalpha), epigenetically regulates in a concerted fashion the transcription of two RA-responsive genes, the RA receptor beta2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1052

    authors: Bistulfi G,Pozzi S,Ren M,Rossetti S,Sacchi N

    更新日期:2006-11-01 00:00:00

  • Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.

    abstract::For many solid tumors, surgical resection remains the gold standard and tumor-involved margins are associated with poor clinical outcomes. Near-infrared (NIR) fluorescence imaging using molecular agents has shown promise for in situ imaging during resection. However, for cancers with difficult imaging conditions, surg...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0878

    authors: Gao RW,Teraphongphom NT,van den Berg NS,Martin BA,Oberhelman NJ,Divi V,Kaplan MJ,Hong SS,Lu G,Ertsey R,Tummers WSFJ,Gomez AJ,Holsinger FC,Kong CS,Colevas AD,Warram JM,Rosenthal EL

    更新日期:2018-09-01 00:00:00

  • Serum micronutrients and the subsequent risk of oral and pharyngeal cancer.

    abstract::To investigate the relationship between serum micronutrients and the subsequent risk of oral and pharyngeal cancer, a nested case-control study was conducted within a cohort of 25,802 adults in Washington County, MD, whose blood samples were collected in 1974 and stored at -70 degrees C for subsequent assays. The seru...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zheng W,Blot WJ,Diamond EL,Norkus EP,Spate V,Morris JS,Comstock GW

    更新日期:1993-02-15 00:00:00

  • Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemia cells.

    abstract::IgG polyclonal antiserum was generated in New Zealand White rabbits immunized with a 16-mer peptide consisting of a specific amino acid sequence at residues corresponding to the sixth to seventh predicted transmembrane domain of the human reduced folate carrier (RFC). Using Western immunoblotting to examine the cytoso...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Trippett TM,Garcia S,Manova K,Mody R,Cohen-Gould L,Flintoff W,Bertino JR

    更新日期:2001-03-01 00:00:00

  • Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo.

    abstract::Effective treatment of malignant carcinomas requires identification of proteins regulating epithelial cell proliferation. To this end, we compared gene expression profiles in murine colonocytes and their c-Myc-transformed counterparts, which possess enhanced proliferative potential. A surprisingly short list of deregu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1953

    authors: Thomas-Tikhonenko A,Viard-Leveugle I,Dews M,Wehrli P,Sevignani C,Yu D,Ricci S,el-Deiry W,Aronow B,Kaya G,Saurat JH,French LE

    更新日期:2004-05-01 00:00:00

  • Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.

    abstract::Although many clinicians and researchers work to understand cancer, there has been limited success to effectively combine forces and collaborate over time, distance, data, and budget constraints. Here we present a workflow template for multidisciplinary cancer therapy that was developed during the 2nd Annual Workshop ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0310

    authors: McGuire MF,Enderling H,Wallace DI,Batra J,Jordan M,Kumar S,Panetta JC,Pasquier E

    更新日期:2013-10-15 00:00:00

  • Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.

    abstract::Friend erythroleukemia cells can be induced to undergo erythroid differentiation by a variety of unrelated compounds. The fact that sodium butyrate causes reversible alterations in growth, morphology, and biochemistry in many cell systems prompted us to reexamine its pattern of induction of differentiation and to comp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Friend C,Zajac-Kaye M,Holland JG,Pogo BG

    更新日期:1987-01-15 00:00:00

  • Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.

    abstract::Cytogenetic analysis has not only provided important information on the pathogenesis of soft tissue tumors but, by disclosing distinct chromosomal rearrangements in different histopathological entities, has also come to serve as a valuable diagnostic tool. Little is known as yet about the potential prognostic impact o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mertens F,Strömberg U,Mandahl N,Dal Cin P,De Wever I,Fletcher CD,Mitelman F,Rosai J,Rydholm A,Sciot R,Tallini G,Van Den Berghe H,Vanni R,Willén H

    更新日期:2002-07-15 00:00:00

  • The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3.

    abstract::PR-104, currently in phase II clinical trials, is a phosphate ester pre-prodrug which is converted in vivo to its cognate alcohol, PR-104A, a prodrug designed to exploit tumor hypoxia. Bioactivation occurs via one-electron reduction to DNA crosslinking metabolites in the absence of oxygen. However, certain tumor cell ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3237

    authors: Guise CP,Abbattista MR,Singleton RS,Holford SD,Connolly J,Dachs GU,Fox SB,Pollock R,Harvey J,Guilford P,Doñate F,Wilson WR,Patterson AV

    更新日期:2010-02-15 00:00:00

  • A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.

    abstract::Although chemokine and growth factor receptors are attractive and popular targets for cancer therapeutic intervention, structure-based targeting of the ligands themselves is generally not considered practical. New evidence indicates that a notable exception to this is macrophage migration inhibitory factor (MIF). MIF,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6227

    authors: Winner M,Meier J,Zierow S,Rendon BE,Crichlow GV,Riggs R,Bucala R,Leng L,Smith N,Lolis E,Trent JO,Mitchell RA

    更新日期:2008-09-15 00:00:00

  • Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.

    abstract::A phenolic amine compound, 4-S-cysteaminylphenol (4-S-CAP), is a potent depigmenting agent. To develop more efficacious antimelanoma agents, we synthesized four homologues of 4-S-CAP: N-acetyl-4-S-CAP (N-Ac-4-S-CAP), alpha-methyl-4-S-CAP, 4-S-homo-CAP, and N,N'-dimethyl-4-S-CAP. We tested these five compounds in mice ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alena F,Jimbow K,Ito S

    更新日期:1990-06-15 00:00:00

  • Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.

    abstract::The laminin alpha5 chain is a component of laminin-10 (alpha5beta1gamma1) and -11 (alpha5beta2gamma1). In this study, we have screened 113 overlapping synthetic peptides from the laminin alpha5 globular domain (G-domain) for cell attachment activity with B16-F10 cells using peptide-coated dishes. Eleven attachment-act...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0129

    authors: Hibino S,Shibuya M,Engbring JA,Mochizuki M,Nomizu M,Kleinman HK

    更新日期:2004-07-15 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • Photosensitization and split-dose recovery in cultured human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative.

    abstract::The photosensitization and survival recovery of cultured EJ human urinary bladder carcinoma cells containing nonexchangeable hematoporphyrin derivative (HPD) were studied. Cultures were incubated at 37 degrees C in growth medium supplemented with HPD (50 micrograms/ml) and 5% fetal bovine serum for 12 h followed by in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bellnier DA,Lin CW

    更新日期:1985-06-01 00:00:00

  • Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.

    abstract::The antitumor effects of methotrexate with 5-fluorouracil against the Sarcoma 180 mouse tumor model were found to be schedule dependent. Pretreatment of tumor-bearing animals with methotrexate significantly enhanced the antitumor activity of the combination relative to simultaneous treatment or to those with methotrex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bertino JR,Sawicki WL,Lindquist CA,Gupta VS

    更新日期:1977-01-01 00:00:00

  • Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.

    abstract::We previously reported that bone marrows of breast cancer patients contained tumor antigen-specific CD8(+) T cells with central or effector memory phenotype. Using a recently developed ret transgenic mouse melanoma model, we now show that bone marrows and tumors of transgenic mice contain high frequencies of CD8(+) T ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1464

    authors: Umansky V,Abschuetz O,Osen W,Ramacher M,Zhao F,Kato M,Schadendorf D

    更新日期:2008-11-15 00:00:00

  • Mutagenic processing of ethylation damage in mammalian cells: the use of methoxyamine to study apurinic/apyrimidinic site-induced mutagenesis.

    abstract::The aldehyde reagent methoxyamine is able to interact with apurinic/apyrimidinic sites formed in vivo within cells and displays both an anti-cytotoxic and an antimutagenic activity on N-ethyl-N'-nitro-N-nitrosoguanidine-induced DNA damage in Chinese hamster ovary cells. To clarify the underlying mechanism we have exam...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fortini P,Calcagnile A,Vrieling H,van Zeeland AA,Bignami M,Dogliotti E

    更新日期:1993-03-01 00:00:00